Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

NCT02615002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

371

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Piromelatine
DRUG: Placebo

Sponsor

Neurim Pharmaceuticals Ltd.